ELIZABETH EVANS: Open Payments
NPI 1053953059 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 15 payments from 7 companies in 2025. Trend: 2023 $289 · 2024 $1,810 · 2025 $887
Food & beverage: $887
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $277 |
| GENZYME CORPORATION | 5 | $163 |
| Novo Nordisk Inc | 2 | $153 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $104 |
| ABBVIE INC. | 2 | $46 |
| Lilly USA, LLC | 1 | $18 |
Products named: DUPIXENT, REPATHA, Ozempic, TEZSPIRE, CREON, OTEZLA, LINZESS, MOUNJARO.
Industry payments across NY — which companies pay providers there.
